Kelly Eagen, MD

Learn more about Dr. Eagen’s work with UW Health »

Dr. Kellene (Kelly) Eagen is an Assistant Professor in the Addiction Medicine program at University of Wisconsin and Associate Program Director of the Addiction Medicine Fellowship. Her appointment includes clinical responsibilities that focus on patient care and teaching Addiction Medicine fellows, residents, medical students and other learners. She provides care on the UW Hospital Consult Service, as well as at the Access Wingra Clinic and the UW HIV Clinic. In addition to her clinical work, she has academic, educational, and research responsibilities that relate to Addiction Medicine including directing the Family Medicine and medical student electives in Addiction Medicine.

Dr. Eagen has a medical degree from the University of Chicago Pritzker School of Medicine in Chicago, Illinois. After completing her education, she completed the University of California San Francisco Family and Community Medicine Residency at Zuckerberg San Francisco General Hospital. She also completed a fellowship in the California Healthcare Foundation Leadership Program. Before coming to the Department of Family Medicine and Community Health, Dr. Eagen worked for the San Francisco Department of Public Health as the Medical Director of the San Francisco Medical Respite and Sobering Center and Medical Director of Permanent Supportive Housing Nursing Services, as well working as a primary care provider for adults experiencing homelessness at the Tom Waddell Urban Health Clinic. In San Francisco she retained an appointment with the University of California San Francisco serving as attending physician for the Family Medicine Inpatient Service at Zuckerberg San Francisco General and as community preceptor for medical students in the outpatient setting.

Dr. Eagen’s specific professional interests include addiction medicine and treatment of substance use disorders, caring for adults experiencing homelessness and living in permanent supportive housing, and providing HIV and Hepatitis C treatment. She is a co-founder of End Hep C SF, a collective impact initiative in San Francisco aimed to eliminate HCV as a public health threat, and she championed the expansion of primary care-based HCV treatment throughout the SF DPH.